Metastasectomy

By examining tumor types individually, however, it is seen that certain histologies (adrenocortical carcinoma, alveolar soft part sarcoma, osteosarcoma) mandate surgical metastasectomy for patient survival.

With the potential for long-term survival, the cost-effectiveness of pulmonary metastasectomy is substantial particularly when compared to chemotherapy alone ($14,357 per life-year gained for PM vs. $104,210 for chemotherapy alone.